XK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.24789956146287E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62436730732907E-12 |
Normal-vs-Stage2 |
1.086310E-02 |
Normal-vs-Stage3 |
9.622200E-01 |
Normal-vs-Stage4 |
5.874000E-01 |
Stage1-vs-Stage2 |
4.844400E-01 |
Stage1-vs-Stage3 |
6.479000E-03 |
Stage1-vs-Stage4 |
4.343500E-02 |
Stage2-vs-Stage3 |
8.742400E-02 |
Stage2-vs-Stage4 |
5.472100E-02 |
Stage3-vs-Stage4 |
6.446200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.93439997353551E-09 |
Normal-vs-AfricanAmerican |
6.33919999999399E-05 |
Normal-vs-Asian |
5.935200E-01 |
Caucasian-vs-AfricanAmerican |
7.758600E-01 |
Caucasian-vs-Asian |
4.791000E-01 |
AfricanAmerican-vs-Asian |
5.053800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.24344978758018E-14 |
Normal-vs-Female |
2.305600E-01 |
Male-vs-Female |
1.121540E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.490460E-02 |
Normal-vs-Extreme_Weight |
1.62625468647093E-12 |
Normal-vs-Obese |
4.616400E-02 |
Normal-vs-Extreme_Obese |
4.07469946672734E-10 |
Normal_Weight-vs-Extreme_Weight |
9.384700E-03 |
Normal_Weight-vs-Obese |
9.540000E-01 |
Normal_Weight-vs-Extreme_Obese |
9.021200E-03 |
Extreme_Weight-vs-Obese |
2.501600E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.376600E-01 |
Obese-vs-Extreme_Obese |
2.240000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.970600E-01 |
Normal-vs-Age(41-60Yrs) |
1.46729961514325E-10 |
Normal-vs-Age(61-80Yrs) |
7.53730411418019E-13 |
Normal-vs-Age(81-100Yrs) |
7.85815856829686E-13 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.205800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.067700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.557500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.634600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.946000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.745850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62547753035369E-12 |
Normal-VS-Type2 PRCC |
1.17349999995131E-06 |
Normal-VS-KIRP CIMP |
1.103780E-02 |
Normal-VS-Unclassified PRCC |
5.45199996260237E-10 |
Type1 PRCC-VS-Type2 PRCC |
8.390300E-04 |
Type1 PRCC-VS-KIRP CIMP |
2.455000E-03 |
Type1 PRCC-VS-Unclassified PRCC |
2.298800E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.316800E-03 |
Type2 PRCC-VS-Unclassified PRCC |
8.718400E-02 |
KIRP CIMP-VS-Unclassified PRCC |
2.999500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.21649999973839E-07 |
Normal-vs-N1 |
1.806040E-01 |
Normal-vs-N2 |
6.286600E-01 |
N0-vs-N1 |
1.109970E-02 |
N0-vs-N2 |
2.937000E-01 |
N1-vs-N2 |
8.916200E-01 |
|
|